Acadian Asset Management
ACER

Acadian Asset Management’s Acer Therapeutics Inc ACER Stock Holding History

Acadian Asset Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-265
Closed -$6K – 1565
2016
Q1 		$6K Sell
265
-30
-10% -$657 ﹤0.01% 1247
2015
Q4 		$9K Buy
+295
New +$9.76K ﹤0.01% 1253

Other funds holding ACER

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Acadian Asset Management's ACER Position: Q2 2016 in Review

Acadian Asset Management sold out of Acer Therapeutics Inc (ACER) in Q2 2016, closing a stake of 265 shares — an estimated $6K sold.

Acadian Asset Management first reported a position in ACER in Q4 2015 and held it in 2 quarters. The position peaked at $9K in Q4 2015. 11 funds tracked by Wall St. Rank hold ACER as of Q2 2016.

  • Acadian Asset Management reported no remaining Acer Therapeutics Inc position as of Q2 2016 after selling out during the quarter.
  • Acadian Asset Management sold 265 Acer Therapeutics Inc shares in Q2 2016, an estimated $6K.
  • Acadian Asset Management first reported a position in Acer Therapeutics Inc in Q4 2015 and held it in 2 quarters.
  • Acadian Asset Management's Acer Therapeutics Inc position peaked at $9K in Q4 2015.
  • 11 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2016.

Based on Acadian Asset Management's 13F filing for Q2 2016, filed 19 Jul 2016.